Unprecedented: COVID-19 Litigation Insights, Volume 2, Issue 8

Spilman Thomas & Battle, PLLC

Welcome to the eighth issue of the 2021 edition of Unprecedented. Perhaps the biggest news from these last two weeks was the decision to suspend administration of the Johnson & Johnson vaccine pending investigation into blood clots experienced by six of the vaccine’s millions of recipients. Beyond its impact on achieving the Biden administration’s vaccination goals, it has also prompted significant discussion about its potential to cause an uptick in vaccine hesitancy. That could have impacts on public health measures meant to slow the spread of COVID-19, which could in turn have broader impacts on the economy. The exact consequences remain to be seen, however, and we continue to track impacts from the COVID-19 pandemic on mass gatherings, insurance coverage, and even the right to a speedy trial. Join us as we discuss these and other issues.

Please see full Newsletter below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Spilman Thomas & Battle, PLLC | Attorney Advertising

Written by:

Spilman Thomas & Battle, PLLC

Spilman Thomas & Battle, PLLC on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.